Sector portfolio · VC firm · United States
Hatteras Venture Partners' Biotech portfolio
Hatteras Venture Partners has backed 31 Biotech startups in rounds we track, $2.4B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.
31startups backed
4stages
$2.4Braised between them
Series Abiggest stage
Series A
10
Funding by segment
- Series A$386M10
- Series C and later$1.3B7
- Stage not reported$105M7
- Series B$601M7
Where they are based
- United States27$2.3B
- Canada3$76M
United States
CanadaFounded
3Earlier
12
213
314
115
216
217
118
319
520
21
22
23
24
25
26
9 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M5
- $10M to $50M17
- $50M to $250M8
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
22 of 31 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States27
- Canada3
Startups by country, 2 countries in all.
Segment by segment
Series A
10 startups · $386M raised
Axonis TherapeuticsAxonis Therapeutics is a Boston-based biotechnology company founded in 2019, focused on developing innovative oral therapies for nUnited States$115M
Code BiotherapeuticsCode Biotherapeutics (Code Bio) is a biotechnology company founded in 2020, based in Hatfield, Pennsylvania.United States$75M
RibometrixRibometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases.United States$45M
Specific BiologicsSpecific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.Canada$36M- QQpexUnited States$33M
- TTTrefoil TherapueitcsUnited States$28M
Qvella CorporationQvella Corporation is a leader in molecular diagnostics focused on improving the speed and efficiency of diagnosing sepsis and bloCanada$20M
Spyryx BiosciencesSpyryx Biosciences develops a next-generation therapeutics for obstructive lung diseases.United States$18M
Series C and later
7 startups · $1.3B raised
Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
Elligo Health ResearchElligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.United States$160M
Atsena TherapeuticsAtsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments forUnited States$150M
Clearside BiomedicalClearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.United States$72M- PPhaseBioUnited States$50M
Rodin TherapeuticsRodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.United States$40M- EHElligo HealthUnited States$36M
Stage not reported
7 startups · $105M raised
Veralox TherapeuticsVERALOX Therapeutics is a clinical-stage biotechnology company based in Frederick, Maryland.United States$41M
Trefoil TherapeuticsTrefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.United States$33M
Artizan BiosciencesArtizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.United States$14M
BEKHealthBEKhealth is an AI-powered clinical intelligence company that enhances electronic health record (EHR) data for clinical research.United States$9.0M
Boston Immune Technologies & TherapeuticsThis company is a Boston-based biopharmaceutical company developing immune-based approaches.United States$4.0M
ORIG3NORIG3N is a biotechnology company based in Boston, founded in 2014.United States$3.1M
Altis BiosystemsAltis Biosystems is a scientific innovation company based in Durham, NC, focused on advancing pre-clinical drug discovery.United States$2.1M
Series B
7 startups · $601M raised
CREATE MedicinesCREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts.United States$195M
Tune TherapeuticsTune Therapeutics is a biotechnology company based in Durham, North Carolina, founded in 2020.United States$175M
Vigil NeuroscienceVigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.United States$130M- NNeuroTronikNeuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.United States$36M
CoferonCoferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells.United States$28M- QQvellaCanada$20M
Incyclix BioIncyclix Bio, LLC is a biotechnology company based in Research Triangle Park, North Carolina, founded in 2020 by experts in cyclinUnited States$16M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Hatteras Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCo-investorsWho invests with Hatteras Venture Partners36 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179BSector portfolioSequoia Capital's AI portfolio209 startups · $543B
Raising from investors like Hatteras Venture Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.